Oral nano‐curcumin formulation efficacy in management of mild to moderate hospitalized coronavirus disease ‐19 patients: An open label nonrandomized clinical trial
Niloofar Saber‐moghaddam, Soofia Salari, Sepideh Hejazi, Mahnaz Amini, Zhila Taherzadeh, Saeed Eslami, Seyed Mahdi Rezayat, Mahmoud Reza Jaafari, Sepideh Elyasi
Phytotherapy Research, doi:10.1002/ptr.7004
Curcumin is proposed as a potential treatment option for coronavirus disease-19 by inhibiting the virus entrance, encapsulation and replication, and modulating various cellular signaling pathways. In this open-label nonrandomized clinical trial, efficacy of nano-curcumin oral formulation has been evaluated in hospitalized patients with mild-moderate COVID-19. Forty-one patients who fulfilled the inclusion criteria were allocated to nano-curcumin (n = 21) group (Sinacurcumin soft gel, contains 40 mg curcuminoids as nanomicelles, two capsules twice a day) or control (n = 20) group, for 2 weeks. Patients' symptoms and laboratory data were assessed at baseline and during follow-up period. Most of symptoms including fever and chills, tachypnea, myalgia, and cough resolved significantly faster in curcumin group. Moreover, SaO 2 was significantly higher in treatment group after 2, 4, 7, and 14 days of follow-up and lymphocyte count after 7 and 14 days. Duration of supplemental O 2 use and hospitalization was also meaningfully shorter in treatment group. It is also noteworthy to mention that no patient in treatment group experienced deterioration of infection during follow-up period, but it occurred in 40% of control group. Oral curcumin nano-formulation can significantly improve recovery time in hospitalized COVID-19 patients. Further randomized placebo controlled trials with larger sample size are recommended.
References
Abdollahi, Momtazi, Johnston, Sahebkar, Therapeutic effects of curcumin in inflammatory and immune-mediated diseases: A nature-made jack-of-all-trades?, Journal of Cellular Physiology,
doi:10.1002/jcp.25778Akbari, Kariznavi, Jannati, Elyasi, Tayarani-Najaran, Curcumin as a preventive or therapeutic measure for chemotherapy and radiotherapy induced adverse reaction: A comprehensive review, Food and Chemical Toxicology,
doi:10.1016/j.fct.2020.111699Avasarala, Zhang, Liu, Wang, London et al., Correction: Curcumin modulates the inflammatory response and inhibits subsequent fibrosis in a mouse model of viral-induced acute respiratory distress syndrome, PLoS One,
doi:10.1371/journal.pone.0057285Avasarala, Zhang, Liu, Wang, London et al., Curcumin modulates the inflammatory response and inhibits subsequent fibrosis in a mouse model of viral-induced acute respiratory distress syndrome, PLoS One,
doi:10.1371/journal.pone.0057285Biswas, Mcclure, Jimenez, Megson, Rahman, Curcumin induces glutathione biosynthesis and inhibits NF-κB activation and interleukin-8 release in alveolar epithelial cells: Mechanism of free radical scavenging activity, Antioxidants & Redox Signaling,
doi:10.1089/ars.2005.7.32Castro Rocha, Renato De Assis, Curcumin as a potential treatment for COVID-19, Phytotherapy Research,
doi:10.1002/ptr.6745Gupta, Patchva, Koh, Aggarwal, Discovery of curcumin, a component of golden spice, and its miraculous biological activities, Clinical and Experimental Pharmacology and Physiology,
doi:10.1111/j.1440-1681.2011.05648.xHatamipour, Sahebkar, Alavizadeh, Dorri, Jaafari, Novel nanomicelle formulation to enhance bioavailability and stability of curcuminoids, Iranian Journal of Basic Medical Sciences,
doi:10.22038/ijbms.2019.32873.7852Jain, Rains, Croad, Larson, Jones, Curcumin supplementation lowers TNF-α, IL-6, IL-8, and MCP-1 secretion in high glucosetreated cultured monocytes and blood levels of TNF-α, IL-6, MCP-1, glucose, and glycosylated hemoglobin in diabetic rats, Antioxidants & Redox Signaling,
doi:10.1089/ars.2008.2140Jäger, Lowery, Calvanese, Joy, Purpura et al., Comparative absorption of curcumin formulations, Nutrition Journal,
doi:10.1186/1475-2891-13-11Kloesch, Becker, Dietersdorfer, Kiener, Steiner, Anti-inflammatory and apoptotic effects of the polyphenol curcumin on human fibroblast-like synoviocytes, International Immunopharmacology,
doi:10.1016/j.intimp.2013.01.003Kulkarni, Kumar, Tevethia, Premkumar, Arab et al., Systematic review with meta-analysis: Liver manifestations and outcomes in COVID-19, Alimentary Pharmacology & Therapeutics,
doi:10.1111/apt.15916Kumar-M, Mishra, Jha, Shukla, Choudhury et al., Coronavirus disease (COVID-19) and the liver: A comprehensive systematic review and meta-analysis, Hepatology International,
doi:10.1007/s12072-020-10071-9Moballegh Naseri, Abadi, Poormoghadam, Zarrabi, Keyhanvar et al., Curcumin delivery mediated by bio-Based nanoparticles, A Review. Molecules
Moghadamtousi, Abdul Kadir, Hassandarvish, Tajik, Abubakar et al., A review on antibacterial, antiviral, and antifungal activity of curcumin, BioMed Research International,
doi:10.1155/2014/186864Mollazadeh, Cicero, Blesso, Pirro, Majeed et al., Immune modulation by curcumin: The role of interleukin-10, Critical Reviews in Food Science and Nutrition,
doi:10.1080/10408398.2017.1358139Mounce, Cesaro, Carrau, Vallet, Vignuzzi, Curcumin inhibits Zika and chikungunya virus infection by inhibiting cell binding, Antiviral Research,
doi:10.1016/j.antiviral.2017.03.014Nelson, Dahlin, Bisson, Graham, Pauli et al., The essential medicinal chemistry of curcumin, Journal of Medicinal Chemistry
Noor, Islam, Prevalence and associated risk factors of mortality among COVID-19 patients: A meta-analysis, Journal of Community Health,
doi:10.1007/s10900-020-00920-xPraditya, Kirchhoff, Brüning, Rachmawati, Steinmann et al., Anti-infective properties of the golden spice curcumin, Frontiers in Microbiology
Prasad, Tyagi, Curcumin and its analogues: A potential natural compound against HIV infection and AIDS, Food & Function,
doi:10.1039/c5fo00485cRaflee, Nelson, Manley, Wellner, Floer et al., Effect of curcumin on acidic pH-induced expression of IL-6 and IL-8 in human esophageal epithelial cells (HET-1A): Role of PKC, MAPKs, and NF-ĸB, American Journal of Physiology-Gastrointestinal and Liver Physiology,
doi:10.1152/ajpgi.90428.2008Richardson, Griffin, Tucker, Smith, Oechsle et al., Baricitinib as potential treatment for 2019-nCoV acute respiratory disease, Lancet,
doi:10.1016/S0140-6736(20)30304-4Rodriguez-Morales, Cardona-Ospina, Gutiérrez-Ocampo, Villamizar-Peña, Holguin-Rivera et al., Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis, Travel Medicine and Infectious Disease,
doi:10.1016/j.tmaid.2020.101623Roy, Sarkar, Celik, Ghosh, Basu et al., Can concomitant use of zinc and curcumin with other immunityboosting nutraceuticals be the arsenal against COVID-19?, Phytotherapy Research,
doi:10.1002/ptr.6766Ruan, Yang, Wang, Jiang, Song, Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China, Intensive Care Medicine,
doi:10.1007/s00134-020-05991-xShakoory, Carcillo, Chatham, Amdur, Zhao et al., Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of the macrophage activation syndrome: Re-analysis of a prior Phase III trial, Critical Care Medicine,
doi:10.1097/CCM.0000000000001402Song, Ge, Cai, Zhang, Curcumin protects mice from coxsackievirus B3-induced myocarditis by inhibiting the phosphatidylinositol 3 kinase/Akt/nuclear factor-κB pathway, Journal of Cardiovascular Pharmacology and Therapeutics,
doi:10.1177/1074248413503044Whitehead, Julious, Cooper, Campbell, Estimating the sample size for a pilot randomised trial to minimise the overall trial sample size for the external pilot and main trial for a continuous outcome variable, Statistical Methods in Medical Research,
doi:10.1177/0962280215588241Zahedipour, Hosseini, Sathyapalan, Majeed, Jamialahmadi et al., Potential effects of curcumin in the treatment of COVID-19 infection, Phytotherapy Research,
doi:10.1002/ptr.6738
